From the Journals
Diabetic Retinal Disease Rates Narrow by Diabetes Type
-
By
-
April 15, 2026
-
5 min
By
April 15, 2026
Patients experience reduced monitoring, emotional distress, and gaps in coordinated care during adjuvant therapy
April 15, 2026
Experts explore how analytical science is meeting the challenges shaping GLP-1 therapeutics
April 14, 2026
The remarkable commercial success of GLP-1 receptor agonists is fueling investment, accelerating science, and creating new analytical challenges. Here, we outline the hurdles these peptides present, explore methods for impurity profiling and structural characterization, and consider strategies to keep pace with this fast-moving field.
April 9, 2026